BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...from new investors Solasta Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap, Wellington Partners...
...Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington Partners IP...
BioCentury | Jan 6, 2021
Emerging Company Profile

Kite, Forty Seven vets on board for launch of oncolytic virus start-up IconOVir with $77M series A

...employees: 10Funds raised: $77 millionInvestors: Nextech, Vida Ventures, Two River Group, Bellco Capital, Polaris Partners, GV, Wellington Partners...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...in order to bring its vaccine for Group B Streptococcus through Phase II testing. New investors Sanofi Ventures, Wellington Partners...
BioCentury | Oct 31, 2020
Deals

Oct. 30 Quick Takes: Q32 raises B round; plus CStone-LegoChem, Centrexion, Sidekick

...Health, a Nordic digital therapeutics company, has raised $20 million in a series A round led by Wellington Partners...
BioCentury | Aug 13, 2020
Management Tracks

NHC’s Boutin to head patient advocacy at Novartis; plus changes at Moderna, PIC, Atea, Terns, NBE and Omega

...NBE-Therapeutics AG appointed Erich Schlick as chairman. He is a general partner and managing director at Wellington Partners. ...
BioCentury | Jul 3, 2020
Finance

On heels of $100M raise, Annexon joins burgeoning IPO queue

...RTW Investments and Sphera Funds, plus existing Immatics investors dievini Hopp BioTech, AT Impf and Wellington Partners...
BioCentury | May 26, 2020
Deals

With trio of COVID deals, Merck takes a page from its Ebola strategy

...settings. Themis had raised at least $75.5 million in venture financings from investors such as Wellington Partners...
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...therapy SIRS Therapeutics, a portfolio company of F4 Pharma GmbH, received undisclosed seed funding from Wellington Partners...
...2015. Targets eIF4E - Eukaryotic translation initiation factor 4E Elizabeth S. Eaton and Hongjiang Li, Staff Writers Wellington Partners Mabworks...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...Sphera Funds, an additional undisclosed investor and existing shareholders dievini Hopp BioTech, AT Impf and Wellington Partners...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...and business development. He was director of business development and licensing at Roche (SIX:ROG; OTCQX:RHHBY). Wellington Partners...
...BMS. Elizabeth S. Eaton, Staff Writer Fred Hutchinson Cancer Research Center GlaxoSmithKline plc Provention Bio Inc. Antengene Corp. Revitope Oncology Inc. Compugen Ltd. Wellington Partners Adamas...
Items per page:
1 - 10 of 100
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...from new investors Solasta Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap, Wellington Partners...
...Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington Partners IP...
BioCentury | Jan 6, 2021
Emerging Company Profile

Kite, Forty Seven vets on board for launch of oncolytic virus start-up IconOVir with $77M series A

...employees: 10Funds raised: $77 millionInvestors: Nextech, Vida Ventures, Two River Group, Bellco Capital, Polaris Partners, GV, Wellington Partners...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...in order to bring its vaccine for Group B Streptococcus through Phase II testing. New investors Sanofi Ventures, Wellington Partners...
BioCentury | Oct 31, 2020
Deals

Oct. 30 Quick Takes: Q32 raises B round; plus CStone-LegoChem, Centrexion, Sidekick

...Health, a Nordic digital therapeutics company, has raised $20 million in a series A round led by Wellington Partners...
BioCentury | Aug 13, 2020
Management Tracks

NHC’s Boutin to head patient advocacy at Novartis; plus changes at Moderna, PIC, Atea, Terns, NBE and Omega

...NBE-Therapeutics AG appointed Erich Schlick as chairman. He is a general partner and managing director at Wellington Partners. ...
BioCentury | Jul 3, 2020
Finance

On heels of $100M raise, Annexon joins burgeoning IPO queue

...RTW Investments and Sphera Funds, plus existing Immatics investors dievini Hopp BioTech, AT Impf and Wellington Partners...
BioCentury | May 26, 2020
Deals

With trio of COVID deals, Merck takes a page from its Ebola strategy

...settings. Themis had raised at least $75.5 million in venture financings from investors such as Wellington Partners...
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...therapy SIRS Therapeutics, a portfolio company of F4 Pharma GmbH, received undisclosed seed funding from Wellington Partners...
...2015. Targets eIF4E - Eukaryotic translation initiation factor 4E Elizabeth S. Eaton and Hongjiang Li, Staff Writers Wellington Partners Mabworks...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...Sphera Funds, an additional undisclosed investor and existing shareholders dievini Hopp BioTech, AT Impf and Wellington Partners...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...and business development. He was director of business development and licensing at Roche (SIX:ROG; OTCQX:RHHBY). Wellington Partners...
...BMS. Elizabeth S. Eaton, Staff Writer Fred Hutchinson Cancer Research Center GlaxoSmithKline plc Provention Bio Inc. Antengene Corp. Revitope Oncology Inc. Compugen Ltd. Wellington Partners Adamas...
Items per page:
1 - 10 of 100